Keywords: bayer, lipobay, cleared, uk, its, first, market

Bayer's Lipobay Cleared In The UK, Its First Market

Article | 17 March 1997

Print This

Bayer AG has been granted approval in the UK to market its HMG-CoAreductase inhibitor Lipobay (cerivastatin) for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in